Abstract
Introduction GENERAL acceptance by clinicians of the basic rationale for the use of preoperative irradiation in mammary carcinoma has been slow and grudging and indeed it is only in very recent years that any degree of widespread interest has been demonstrated in combination therapy of this type. At the present time radiotherapists and surgeons in several centers are studying its value in a wide variety of malignant diseases. However, in more than a decade since a previous report from the Toronto General Hospital and the Ontario Cancer Institute 1 there has been no real evidence of gathering momentum in the frequency or the enthusiasm with which preoperative irradiation has been utilized in the management of breast cancer, despite the fact that newer techniques in radiotherapy have provided the surgeon with the re-assurance of skin-sparing irradiation. Nonetheless there has been no effective argument against the validity of the theses on which
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
